United StatesCefazolin in Dextrose, Injection, USP, 2 g/100 mL single-dose infusion bag in 100 mL GALAXY plastic frozen premix (NDC 0338-3508-41), Lot LD175708, exp. 14-Feb-2027, manufactured by Baxter Healthcare Corporation, is being recalled nationwide in the United States (19,032 bags). The product was recalled because of the presence of particulate matter.
What's being recalled
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
Recalling firm: Baxter Healthcare Corporation, Deerfield, IL, United States.
How to identify it
Lot # LD175708, Exp Date: 14-Feb-2027.
The hazard
Presence of Particulate Matter
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)